These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 28502307)

  • 1. [Knock-down of DAB2 interacting protein (DAB2IP) promotes proliferation and inhibits apoptosis of bladder cancer cells].
    Zhang K; Wang W; Wu K; Ding C; Zhu J; DU Y; Guan Z; Wang X; Fan J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 May; 33(5):668-676. PubMed ID: 28502307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of DAB2IP results in cell proliferation and invasion and contributes to unfavorable outcomes in bladder cancer.
    Shen YJ; Kong ZL; Wan FN; Wang HK; Bian XJ; Gan HL; Wang CF; Ye DW
    Cancer Sci; 2014 Jun; 105(6):704-12. PubMed ID: 24684735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miRNA-556-3p promotes human bladder cancer proliferation, migration and invasion by negatively regulating DAB2IP expression.
    Feng C; Sun P; Hu J; Feng H; Li M; Liu G; Pan Y; Feng Y; Xu Y; Feng K; Feng Y
    Int J Oncol; 2017 Jun; 50(6):2101-2112. PubMed ID: 28440444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ATM inhibitor KU55933 sensitizes radioresistant bladder cancer cells with DAB2IP gene defect.
    Zhang T; Shen Y; Chen Y; Hsieh JT; Kong Z
    Int J Radiat Biol; 2015 Apr; 91(4):368-78. PubMed ID: 25585815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of human DAB2IP gene expression in prostate cancer cells results in resistance to ionizing radiation.
    Kong Z; Xie D; Boike T; Raghavan P; Burma S; Chen DJ; Habib AA; Chakraborty A; Hsieh JT; Saha D
    Cancer Res; 2010 Apr; 70(7):2829-39. PubMed ID: 20332235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DAB2IP-knocking down resulted in radio-resistance of breast cancer cells is associated with increased hypoxia and vasculogenic mimicry formation.
    Zhang X; Wang Q; Zhang R; Kong Z
    Int J Radiat Biol; 2023; 99(10):1595-1606. PubMed ID: 36947637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [DAB2IP expression in bladder transitional cell carcinoma and its correlation with clinical outcome].
    Zhu JN; Wu KJ; Guan ZF; Liu LX; Ning ZY; Zhou JC; Wang XY; Fan JH
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2014 Jul; 45(4):591-4. PubMed ID: 25286682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epothilone B confers radiation dose enhancement in DAB2IP gene knock-down radioresistant prostate cancer cells.
    Kong Z; Raghavan P; Xie D; Boike T; Burma S; Chen D; Chakraborty A; Hsieh JT; Saha D
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1210-8. PubMed ID: 20970033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low expression of DAB2IP contributes to malignant development and poor prognosis in hepatocellular carcinoma.
    Zhang X; Li N; Li X; Zhao W; Qiao Y; Liang L; Ding Y
    J Gastroenterol Hepatol; 2012 Jun; 27(6):1117-25. PubMed ID: 22168621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DAB2IP regulates the chemoresistance to pirarubicin and tumor recurrence of non-muscle invasive bladder cancer through STAT3/Twist1/P-glycoprotein signaling.
    Wu K; Wang B; Chen Y; Zhou J; Huang J; Hui K; Zeng J; Zhu J; Zhang K; Li L; Guo P; Wang X; Hsieh JT; He D; Fan J
    Cell Signal; 2015 Dec; 27(12):2515-23. PubMed ID: 26410305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of DAB2IP expression in human urothelial carcinoma is associated with poorer recurrence-free survival.
    Jou YC; Tsai YS; Chen SY; Hsieh HY; Tsai HT; Tzai TS
    Virchows Arch; 2016 Jun; 468(6):733-40. PubMed ID: 27003158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of Human DAB2IP Gene Expression in Renal Cell Carcinoma Results in Resistance to Ionizing Radiation.
    Yun EJ; Lin CJ; Dang A; Hernandez E; Guo J; Chen WM; Allison J; Kim N; Kapur P; Brugarolas J; Wu K; He D; Lai CH; Lin H; Saha D; Baek ST; Chen BPC; Hsieh JT
    Clin Cancer Res; 2019 Jul; 25(14):4542-4551. PubMed ID: 31000589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Smurf1 regulation of DAB2IP controls cell proliferation and migration.
    Li X; Dai X; Wan L; Inuzuka H; Sun L; North BJ
    Oncotarget; 2016 May; 7(18):26057-69. PubMed ID: 27036023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of DAB2IP promotes colorectal cancer invasion and metastasis by translocating hnRNPK into nucleus to enhance the transcription of MMP2.
    Zhu XH; Wang JM; Yang SS; Wang FF; Hu JL; Xin SN; Men H; Lu GF; Lan XL; Zhang D; Wang XY; Liao WT; Ding YQ; Liang L
    Int J Cancer; 2017 Jul; 141(1):172-183. PubMed ID: 28335083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of DAB2IP Inhibits Ras Activity and Tumorigenesis in Human Pancreatic Cancer Cells.
    Duan Y; Yin X; Lai X; Liu C; Nie W; Li D; Xie Z; Li Z; Meng F
    Technol Cancer Res Treat; 2020; 19():1533033819895494. PubMed ID: 32336215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting MACC1 by RNA interference inhibits proliferation and invasion of bladder urothelial carcinoma in T24 cells.
    Xu ST; Ding X; Ni QF; Jin SJ
    Int J Clin Exp Pathol; 2015; 8(7):7937-44. PubMed ID: 26339359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DAB2IP in cancer.
    Liu L; Xu C; Hsieh JT; Gong J; Xie D
    Oncotarget; 2016 Jan; 7(4):3766-76. PubMed ID: 26658103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of DAB2IP promotes cancer stem cell like signatures and indicates poor survival outcome in colorectal cancer.
    Min J; Liu L; Li X; Jiang J; Wang J; Zhang B; Cao D; Yu D; Tao D; Hu J; Gong J; Xie D
    Sci Rep; 2015 Nov; 5():16578. PubMed ID: 26564738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-542-3p suppresses cellular proliferation of bladder cancer cells through post-transcriptionally regulating survivin.
    Zhang J; Wang S; Han F; Li J; Yu L; Zhou P; Chen Z; Xue S; Dai C; Li Q
    Gene; 2016 Apr; 579(2):146-52. PubMed ID: 26723509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DAB2IP down-regulates HSP90AA1 to inhibit the malignant biological behaviors of colorectal cancer.
    Zhang M; Peng Y; Yang Z; Zhang H; Xu C; Liu L; Zhao Q; Wu J; Wang H; Liu J
    BMC Cancer; 2022 May; 22(1):561. PubMed ID: 35590292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.